Cardiovascular Journal of Africa: Vol 25 No 5 (September/October 2014)

44 / 74

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 5, September/October 2014 238 AFRICA
tor of mortality in hypertension. Hypertension 2011; 57: 702–709.
40. Kassler WJ, Haley C, Jones WK, Gerber AR, Kennedy EJ, George
JR, et al. Performance of rapid onsite human immunodeficiency virus
antibody assay in public health setting. J Clin Microbiol 1995; 33:
2899–2902.
41. Allain TJ, van Oosterhout JJ, Douglas GP, Joukes S, Gadabu OJ, Darts
GP, et al. Applying lessons learnt from the ‘DOTS’ tuberculosis model
to monitoring and evaluating persons with diabetes mellitus in Blantyre,
Malawi. Trop Med Int Health 2011; 9: 1077–1084.
Why you should publish with CVJA
• Increased international exposure (indexed in Pubmed, Medline,
Pubmed Central, Scopus, Embase and Thompson Reuters/ISI)
• Quick return on submissions
• Changing patterns of heart disease in Africa get more exposure
than in other journals
• Acceptance of diabetes studies as vascular studies in CVJA
• African studies are given preference
• Well-illustrated interventional studies are needed for CME in
Africa (full website support capability)
• Instructions for authors on
• A PowerPoint presentation for new authors: 'How to write a
scientific paper'
• Submit your manuscript online at
Contact us on
CVJA has the capability of publishing on Pubmed Central
CardioVascular Journal of Africa (official journal for PASCAR)